Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on May 10, 2026, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 48,800 ...

Guggenheim analyst Vamil Divan reiterated a Buy rating on Savara yesterday and set a price target of $11.00. The company’s shares closed yesterday at $5.08. Claim 55% Off TipRan ...

The EMBARK Awareness initiative is working to raise awareness of APOL-1 mediated kidney disease among high-risk populations ...

Ligand Pharmaceuticals delivered an upbeat earnings call that balanced robust current performance with an ambitious expansion plan. Management highlighted strong royalty growth, rising adjusted ...

ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal diseases with a total accessible market >$100 ...

New understanding about the pathophysiology of the condition, along with new clinical trial endpoints for approval, have ...

United Therapeutics Corporation announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide a company overview and update on Tuesday, May 19, 2026, from 9:30 to 9:55 a.m.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The United States market has shown robust performance, climbing 1.5% in the last week and an impressive 26% over the past year, with earnings projected to grow by 17% annually. In this thriving ...

The Lutzie 43 Foundation selected 20 college and high school students as recipients of the 2026 $4,300 Prepared for Life (PFL ...

According to the Social Security Administration (SSA), nearly 70 million Americans received Social Security benefits in July ...